Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Dec 21, 2021 5:10pm
97 Views
Post# 34252380

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Omicron

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:OmicronThe news is just out here, 80% of covid cases in the province of Quebec are from omicron. We got a bit above 5,000 new cases today and 8 deaths. All that with 90% vaccination rate. Imagine what it will do in some states in the US that only have 60% vaccination rate.

While taking a walk in a snowy forest up north here, I just listened to a podcast featuring Dr. Eric Topol. He too thinks that the Pfizer antiviral drug could be a big part of the solution to covid, at least with the variants we have now. The problem is that the drug will come too late for most in this omicron wildfire.


jfm1330 wrote: I was giving the example of Quebec as something positive with our 4 deaths per day for 8.5 M of population, with 90% vaccination rate for those 12 or older. But imagine if we would have mandatory vaccination (significative fines for the unvaxed), our vaccination rate would be somewhere above 97% and we would not have more than one death per day on average, probably less. We still have 4 deaths per day because of our 10 % of unvaxed people. Deniers, conspirasionists and selfish people can say what they want, the facts are stubborn. The higher the vaccination rate is, the more lives are saved. This is the reality, and here, people will rush to get the third dose. It will help to minimize the number of deaths when omicron will totally take over with its very high transmisibility.




<< Previous
Bullboard Posts
Next >>